Deck Bio Unveils Innovative Multi-Target T Cell Engager for Solid Tumors Ahead of AACR 2026 Deck Bio has introduced a multi-target T cell engager platform aimed at addressing solid tumors, showcasing promising preclinical data at AACR 2026.

Deck Bio Unveils Innovative Multi-Target T Cell Engager for Solid Tumors Ahead of AACR 2026 #USA #Cambridge #T_cell_engagers #Deck_Bio #DBXO-1

Ouro Medicines Unveils Innovative Treatments for Immune-Mediated Disorders Ouro Medicines has just launched, backed by $120 million funding, aiming to revolutionize immune-mediated disease treatment through groundbreaking T cell therapies.

Ouro Medicines Unveils Innovative Treatments for Immune-Mediated Disorders #United_States #San_Francisco #biotechnology #Ouro_Medicines #T_cell_engagers